HIGHLIGHTS
- who: Endogenous c-Jun N-terminal kinase and colleagues from the consents were obtained from all patients and the study was approved by the institutional review board of Koc UniversityChemicals and reagents have published the research: Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells, in the Journal: (JOURNAL)
- what: Our findings warrant further investigations since targeting JNK pathway may provide therapeutic benefit in the treatment of granulosa cell tumors for which currently no curative therapy exists beyond surgery.
- how: The authors utilized fresh tumor . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.